Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 126.04 USD 0.01%
Market Cap: 7.2B USD
Have any thoughts about
Ascendis Pharma A/S?
Write Note

Ascendis Pharma A/S
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ascendis Pharma A/S
Long-Term Debt Peer Comparison

Comparables:
GMAB
ZEAL
B
BAVA
F
FLUO
BIOPOR

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Ascendis Pharma A/S
NASDAQ:ASND
Long-Term Debt
€219.1m
CAGR 3-Years
33%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Long-Term Debt
kr925m
CAGR 3-Years
34%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Zealand Pharma A/S
CSE:ZEAL
Long-Term Debt
kr373.6m
CAGR 3-Years
43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bavarian Nordic A/S
CSE:BAVA
Long-Term Debt
kr82.7m
CAGR 3-Years
-67%
CAGR 5-Years
-29%
CAGR 10-Years
2%
F
Fluoguide AS
STO:FLUO
Long-Term Debt
kr623k
CAGR 3-Years
122%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Long-Term Debt
kr3.5m
CAGR 3-Years
-23%
CAGR 5-Years
24%
CAGR 10-Years
43%

See Also

What is Ascendis Pharma A/S's Long-Term Debt?
Long-Term Debt
219.1m EUR

Based on the financial report for Jun 30, 2024, Ascendis Pharma A/S's Long-Term Debt amounts to 219.1m EUR.

What is Ascendis Pharma A/S's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
47%

Over the last year, the Long-Term Debt growth was -54%. The average annual Long-Term Debt growth rates for Ascendis Pharma A/S have been 33% over the past three years , 47% over the past five years .

Back to Top